National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD, USA.
School of Physics and Astronomy, Raymond & Beverly Sackler Faculty of Exact Sciences, Tel-Aviv University, Tel-Aviv, Israel.
Nat Rev Genet. 2021 Apr;22(4):251-262. doi: 10.1038/s41576-020-00299-4. Epub 2020 Nov 30.
Intratumour heterogeneity and phenotypic plasticity, sustained by a range of somatic aberrations, as well as epigenetic and metabolic adaptations, are the principal mechanisms that enable cancers to resist treatment and survive under environmental stress. A comprehensive picture of the interplay between different somatic aberrations, from point mutations to whole-genome duplications, in tumour initiation and progression is lacking. We posit that different genomic aberrations generally exhibit a temporal order, shaped by a balance between the levels of mutations and selective pressures. Repeat instability emerges first, followed by larger aberrations, with compensatory effects leading to robust tumour fitness maintained throughout the tumour progression. A better understanding of the interplay between genetic aberrations, the microenvironment, and epigenetic and metabolic cellular states is essential for early detection and prevention of cancer as well as development of efficient therapeutic strategies.
肿瘤内异质性和表型可塑性,由一系列体细胞异常以及表观遗传和代谢适应所维持,是使癌症能够抵抗治疗并在环境压力下存活的主要机制。不同体细胞异常(从点突变到全基因组复制)在肿瘤发生和进展中的相互作用的全貌尚不清楚。我们假设,不同的基因组异常通常表现出时间顺序,由突变水平和选择压力之间的平衡决定。重复不稳定首先出现,然后是更大的异常,补偿效应导致整个肿瘤进展过程中保持稳健的肿瘤适应性。更好地理解遗传异常、微环境以及表观遗传和代谢细胞状态之间的相互作用,对于癌症的早期检测和预防以及高效治疗策略的发展至关重要。